Trump's Proposed Tariffs on Generic Drug Imports Raise Concerns for India's Pharmaceutical Industry
The US plans to impose a 100 percent tariff on imported generic medicines from August 2028, increasing to 200 percent a year later, prompting Indian drugmakers to reassess export strategies and manufacturing plans.
Global Pharmaceutical Supply Chain | 23/07/2026 | By News Bureau
ScinoPharm Wins FDA Approval for Glatiramer Acetate Injection
ScinoPharm Taiwan has received US FDA approval for its Glatiramer Acetate Injection for the treatment of multiple sclerosis, marking a significant milestone as the first and only Taiwanese pharmaceutical company to secure FDA approval for this complex generic, and reinforcing Taiwan’s growing role in the global pharmaceutical supply chain.
Global Pharmaceutical Supply Chain | 05/01/2026 | By News Bureau | 200
Nandani Medical Laboratories has entered into a strategic collaboration with Shanghai-based pharmaceutical machinery innovator Xin Weisheng to advance intelligent pharma quality in India.
Global Pharmaceutical Supply Chain | 23/07/2025 | By Dineshwori | 265
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy